summari report robust result close
revenu y/i exceed estim
consensu ep y/i
exceed estim consensu beat
led number factor higher procedur volum
growth system ship well higher gross margin
lower effect tax rate one addit surgeri day
contribut approxim procedur volum
sell day track y/i consist
period last year overal solid quarter driven
strong result manag rais procedur volum growth
outlook y/i gross margin
retir top-end oper expens growth
outlook y/i
key takeaway quarter follow y/i
procedur volum growth robust day-adjust
report acceler stack two-year basi indic
strong demand global system ship increas healthi
high-teen pace trade-in approach peak level repres
system ship quarter global oper
leas continu track one-third system ship
consist level trend slightli
outsid us ou high-singl
digit y/i da vinci system mid-singl
digit y/i procedur consist level
matur procedur acceler sequenti manag
expect trend provid initi
commentari indic us manag
prefer invest leverag next year
rais estim given beat guidanc
rais rais estim account beat
reflect manag revis outlook mention revenu
estim y/i
y/i ep estim
y/i
y/i account higher invest next year
maintain base approxim
continu page
pleas see page rate definit import disclosur
requir analyst certif estimates/forecast
well fargo secur llc seek busi compani
cover research report result investor awar
firm may conflict interest could affect object report
investor consid report singl factor make
compani data secur llc estim reuter
adjust ep exclud amort stock base compens
compani data secur llc estim reuter
result aid strong procedur volum growth nearli y/i includ
 isrg top-lin result aid robust y/i growth procedur volum includ
y/i us y/i ou notabl procedur volum growth acceler stack two-
year basi even adjust sell day differenti impli strong underli demand
 growth driven gener surgeri hernia colorect day-adjust growth rate
consist sequenti quarter cholecystectomi procedur growth acceler
begun repres notabl driver increment procedur manag remain cautiou
overal size address market note see healthi mix new
continu surgeon littl churn increas firefli util bariatr procedur acceler
modestli sequenti even though still area broad emphasi compani within
matur categori gynecolog procedur track mid-singl digit y/i consist
 urolog prostatectomi dvp procedur surpris upsid y/i
growth versu low-single-digit growth manag continu expect growth matur
 procedur moder reflect impli outlook midpoint
procedur volum growth robust y/i da vinci procedur growth ou
track expect y/i growth consist prior year quarter
sequenti growth driven continu strength dvp earlier stage growth
kidney cancer procedur gener surgeri gynecolog china saw modest acceler
procedur volum growth new system placement provid addit capac
increment growth said growth track overal intern procedur volum growth
japan saw robust growth y/i reflect momentum procedur gain
reimburs april manag continu focu surgeon team train japan
build proctor network europ saw growth procedur consist prior quarter
germani particularli strong uk track plan
saw strong y/i growth system ship trade-in near peak level ship
system net trade-in retir quarter compar estim
net respect compani global instal base grew system y/i
consist growth deliv last sever quarter variou item note
quarter first trade-in continu healthi pace activ reflect custom desir
standard platform compani fourth-gener technolog mix trade-in
system ship y/i sequenti manag believ
level may indic peak base histor level trade-in activ robust recent
quarter second leas activ quarter continu made system place
y/i sequenti leas option allow faster market adopt da
vinci appear prudent ahead competit creat recur revenu stream
versu outright purchas tend lumpi leas activ expect variabl quarter-to-
quarter like trend time final saw higher placement latest gener xi
system quarter repres system place quarter versu last quarter
exclud impact oper leas leas buyout approxim
y/i sequenti
provid commentari provid detail commentari januari cfo
marshal mohr highlight certain busi dynam would impact expect continu
invest busi next year result y/i growth oper expens see
substanti opportun ahead expand benefit minimally-invas surgeri
current model y/i growth oper expens margin contract
note expect percentag leas altern financ
arrang continu increas time number trade-in transact level-off
short-term declin time current model leas increas
system ship toward trade-in decreas
next sever year final note expect see increas price negoti
elong negoti timelin competit approach could result variabl quarterli
result expect continu manag busi long-term
sp placement modest phase one da vinci sp launch work
expand clinic clearanc build scale compani ship system versu
sequenti quarter proactiv held back shipment sp endoscop investig robust
concern shipment resum overal manag note custom respons
earli clinic result continu encourag strong util rate korea
broadest set indic approv respect indic expans current
discuss fda regard data requir colorect indic expect
trial follow-up analysi impli indic receiv beyond
manag believ fda regulatori environ continu data-centr new
medic devic indic brought market
metricswfconsensuswfconsensusrevenu placement gross placement net base instal procedur factset wfconsensusrevenu compani report secur llc estim factset visibl alphaactu vs actual vs explicitli state consensu visibl alpha may vari base broker contribut medic technolog
million except per share data fiscal year end decemb servic total good sold excl sbc gross profit ex sbc sg excl sbc excl sbc oper expens excl sbc oper incom excl sbc interest incom net incom tax excl sbc incom tax net incom excl sbc less non-control jv net incom fulli dilut adjust adjust adjust margin excl sbc amort good profit expens incom incom excl sbc amort growthtot good profit ex sbc oper incom excl sbc incom net tax incom excl sbc dilut compani report secur llc estim factset intuit surgic inc
price target nc
base approxim price-to-earnings ep estim repres premium
larg cap med-tech peer risk thesi includ slower expect adopt robot surgeri
gener surgic procedur increas competit
believ adopt us gener surgeri procedur hernia repair colorect
continu drive strong growth next year upcom competit continu spur
acceler robot placement pipelin
intuit surgic pioneer market leader surgic robot surgeri da vinci robot offer
minimally-invas surgeri broad rang surgic procedur includ urolog gynecolog
gener surgeri hernia repair colorect bariatr cardiothorac global instal base
robot perform million procedur world-wide gener
revenu
